Post-authorization safety study (PASS)

A post-authorisation safety study is a study that is conducted after a medicine has been authorised to obtain further information on a medicine's safety, or to measure the effectiveness of risk-management measures. The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing the protocols of imposed PASS and for assessing their results.